Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > lets sell ATE

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Mar 11, 2021 10:09am

136 Views

Post# 32771714

RE:lets sell ATE

Nick80 wrote: Why waste your time and wait for a 2-3x if there are place to get this in 1 week lol

bnxa.v

ATE is just frustrating insider trading shorting up and down up and down - probably plenty of time to come back in a few month and buy for $4 again

If you want to sell, you sell.
Why on earth would you feel compelled to tell others to sell ? To what benefit ?

Been here for almost 4 years and I'm not going anywhere.

: )

<< Previous

Bullboard Posts

Next >>

The top 5 Canadian small-cap AI stocks